CACA guidelines for holistic integrative management of prostate cancer
Abstract Prostate cancer (PC) is an epithelial malignancy occurring in the prostate. PC ranks second in incidence among all male malignancies globally by the latest statistics from the World Health Organization. Notably, China has seen a more rapid increase in PC incidence compared to developed European and American nations. By 2022, the newly reported cases and deaths due to PC in China increased to 134,200 and 47,500, respectively. Thus, early diagnosis and standardized treatment for prostate cancer in China remain far-reaching objectives. Burgeoning research on advanced PC and castration-resistant prostate cancer in recent years have paved the way for a new era of integrated treatment methods including novel endocrine drugs, chemotherapy, targeted therapy, and immunotherapy. Future therapies involve precision treatment guided by genetic testing and individualized integrated treatment as part of a multidisciplinary integrated diagnosis and treatment model for PC. The Genitourinary Oncology Committee of the China Anti-Cancer Association (CACA-GU) has invited multidisciplinary experts across fields including surgery, oncology, pathology, radiology, herbal medicine, physiatry, and psychology to collaboratively write, discuss, and revise guidelines on managing PC. The CACA Guidelines for Holistic Integrative Management of Prostate Cancer includes epidemiology, screening and diagnosis, treatment for localized PC, diagnosis and treatment of PC recurrence after radical prostatectomy, management of metastatic PC, traditional Chinese medicine diagnosis and treatment of PC, and rehabilitation from PC. This guideline aims to standardize the clinical diagnosis and treatment management of PC in China. It is more aligned with China’s clinical practice, highlights Chinese characteristics, and bears significant clinical importance.
Authors
- Yongsheng Yang (ORCID: https://orcid.org/0000-0002-7546-1210)
- Zhongquan Sun
- Jianbin Bi (ORCID: https://orcid.org/0000-0002-7703-4765)
- Denglong Wu
- Baiye Jin (ORCID: https://orcid.org/0000-0002-6667-0424)
- Fangning Wan (ORCID: https://orcid.org/0000-0001-5258-1626)
- Bo Dai (ORCID: https://orcid.org/0000-0003-1383-3864)
- Zhe Hong (ORCID: https://orcid.org/0000-0001-5942-4893)
- Dongwen Wang (ORCID: https://orcid.org/0000-0002-6805-780X)
- Jiasheng Bian
- Xin Gou (ORCID: https://orcid.org/0000-0003-3062-209X)
- Qing Zou (ORCID: https://orcid.org/0000-0002-2729-2491)
- Xinhua Tu
- Lin Qi (ORCID: https://orcid.org/0009-0006-0128-1387)
- Qiang Wei (ORCID: https://orcid.org/0000-0002-3380-4932)
- Jianming Guo (ORCID: https://orcid.org/0000-0002-9300-8401)
- Zhisong He (ORCID: https://orcid.org/0000-0002-1502-4801)
- Chaohong He
- Jinchun Xing
- Nan Liu (ORCID: https://orcid.org/0000-0002-8314-0900)
- Zheng Liu (ORCID: https://orcid.org/0000-0001-8445-1228)
- Shaoxing Zhu
- Aili Zhang (ORCID: https://orcid.org/0000-0001-7953-327X)
- Hong Liao
- Hongkai Wang (ORCID: https://orcid.org/0000-0003-3727-4817)
- Benkang Shi
- Dingwei Ye (ORCID: https://orcid.org/0000-0002-0916-4218)
- Zhiquan Hu
Institutions
- Hebei Medical University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Central South University (CN)
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- Fudan University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- West China Hospital of Sichuan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Peking University Cancer Hospital (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- Zhejiang Cancer Hospital (CN)
- Huadong Hospital (CN)
- Shandong Tumor Hospital (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Sichuan Cancer Hospital (CN)
- Zhongshan Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Peking University First Hospital (CN)
- First Hospital of China Medical University (CN)
- Henan Cancer Hospital (CN)
- Chongqing Cancer Hospital (CN)
- Xiangya Hospital Central South University (CN)
- Tongji Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
- Huazhong University of Science and Technology (CN)
- Zhejiang University (CN)
- Chongqing Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Holistic Integrative Oncology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1007/s44178-024-00118-4
- Citations
- 18
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 7.54